eTest: Real-time, Remote Monitoring System for Home-based HIV Testing Among High-risk Men Who Have Sex With Men

NCT03654690 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 811

Last updated 2025-04-10

Study results available
· View outcomes & findings →

Summary

The proposed research will conduct a fully-powered efficacy trial of this approach in areas with large populations of AA and H/L MSM and high HIV incidence: Jackson, MS, Los Angeles, CA, and Boston, MA. High-risk MSM who have not tested for HIV in the last year will be recruited from MSM-oriented "hook-up" mobile apps, and assigned to receive either (1) HBST with post-test phone counseling/referral ("eTEST" condition), (2) "standard" HBST without active follow-up, or (3) reminders to get tested for HIV at a local clinic ("control" condition) at three month intervals over the course of 12 months. The investigators will explore the impact of the eTEST system on key outcomes, including rates of HIV testing, receipt of additional HIV prevention services, and PrEP initiation, compared with standard HBST or clinic-based testing reminders alone. The investigators will also explore the cost effectiveness of the eTEST system under various scenarios compared with relying on traditional, clinic-based testing alone.

Conditions

  • HIV Infections

Interventions

DIAGNOSTIC_TEST

HIV self-test

Home delivery of HIV self-test kits (OraSure OraQuick Rapid HIV test)

BEHAVIORAL

Counseling

Post-Test HIV Risk ReductionCounseling

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • University of Southern California

    collaborator OTHER
  • The Miriam Hospital

    collaborator OTHER
  • University of Mississippi Medical Center

    collaborator OTHER
  • Brown University

    lead OTHER

Principal Investigators

  • Tyler B Wray, PhD · Brown University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-23
Primary Completion
2023-05-01
Completion
2023-05-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03654690 on ClinicalTrials.gov